髋关节假体周围感染行清创、抗生素及假体保留的功能结局:病例对照研究
该病例对照研究回顾性分析了1997至2013年82例确诊感染的原发全髋关节置换术后行清创、抗生素及假体保留(DAIR)的病例,并与120例原发全髋置换及66例两阶段翻修病例按性别和年龄匹配比较。DAIR组5年生存率(98%;95%CI 94至100)与原发全髋置换组(98%;95%CI 95至100)相似,平均牛津髋关节评分(OHS)低于原发全髋置换组但优于两阶段翻修组。作者认为DAIR的感染根除能力和并发症率与两阶段翻修相似,且功能结局优于两阶段翻修。
要点
- DAIR治疗髋关节假体周围感染的感染根除率、并发症率和再手术率与两阶段翻修相似。
- DAIR成功根除感染后5年生存率(98%;95%CI 94至100)与原发全髋置换(98%;95%CI 95至100)相似。
- 仅需一次DAIR即根除感染的患者平均OHS(41;20至48)与原发全髋置换组相似。
核心结论
- DAIR的并发症率和感染根除能力与两阶段翻修相似。
- 本研究强调交换模块化组件以提高感染根除机会。
- 这是首个显示DAIR在功能结局方面优于两阶段翻修的研究。
研究设计与样本
- 回顾性病例对照研究,纳入1997至2013年本机构因确诊的原发髋关节置换术后感染行DAIR的病例82例。
- 对照组为按性别和年龄匹配的原发全髋置换队列120例和因感染行两阶段翻修的队列66例。
- DAIR时平均年龄69岁(33至87),平均随访8年(2至17;标准差5)。
主要发现
- 52例(63%)DAIR用于早期假体周围感染(少于六周)。
- 早期假体周围感染且症状出现至DAIR术中交换模块化组件间隔少于一周者,感染根除成功率更高。
- DAIR组与两阶段翻修组的感染根除率、并发症率和再手术率相似。
- DAIR成功根除感染的患者5年生存率为98%(95%CI 94至100),与原发全髋置换组的98%(95%CI 95至100)相似(n=43;p=0.3)。
- DAIR组平均OHS为38(12至48),低于原发全髋置换组的42(15至48)(p=0.02),但高于两阶段翻修组的31(0至48)(p=0.008)。
临床怎么用
- 作者强调DAIR术中交换模块化组件以提高感染根除机会。
- 作者认为DAIR在功能结局方面优于两阶段翻修。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Advocates of debridement, antibiotics and implant retention (DAIR) in hip periprosthetic joint infection (PJI) argue that a procedure not disturbing a sound prosthesis-bone interface is likely to lead to better survival and functional outcome compared with revision. This case-control study aims were to compare outcome of DAIRs for infected primary total hip arthroplasty (THA) with outcomes following primary THA and two-stage revision of infected primary THAs. PATIENTS AND METHODS: We retrospectively reviewed all DAIRs, performed for confirmed infected primary hip arthropasty (n = 82) at out institution, between 1997 and 2013. Data recorded included full patient information and type of surgery. Outcome measures included complications, mortality, implant survivorship and functional outcome. Outcome was compared with two control groups matched for gender and age; a cohort of primary THAs (n = 120) and a cohort of two-stage revisions for infection (n = 66). RESULTS: Mean age at DAIR was 69 years (33 to 87) and mean follow-up was eight years (2 to 17; standard deviation (sd) 5). A total of 52 (63%) of DAIRs were for early PJI (less than six weeks). Greater success in the eradication of infection with DAIR was identified with early PJI, comprising an interval less than a week between onset of symptoms and exchange of modular components with the DAIR procedure. Eradication of infection, complications and re-operation rates were similar in the DAIR and two-stage revision groups. For hips with successful eradication of infection with DAIR, the five-year survival (98%; 95% confidence interval (CI) 94 to 100) was similar to the primary THA group (98%; 95% CI 95 to 100) (n = 43; p = 0.3). The DAIR group had inferior mean Oxford Hip Scores (OHS) (38; 12 to 48) compared with the primary THA group (42; 15 to 48) (p = 0.02) but a significantly better mean OHS compared with the two-stage revision group (31; 0 to 48) (p = 0.008). Patients who required only one DAIR for eradication of infection had a similar mean OHS (41; 20 to 48) to the primary THA group (p = 0.2). CONCLUSION: The DAIR procedure is associated with a similar complication rate and ability to eradicate infection as two-stage revision. This study emphasises the need for exchange of modular components for improved chances of eradication of infection. This is the first study showing that DAIR is better than a two-stage revision regarding functional outcome. Cite this article: Bone Joint J 2017;99-B:614-22.
引用
- Grammatopoulos G, Bolduc ME, Atkins BL, et al. Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case-control study. Bone Joint J. 2017. PMID: 28455470. doi:10.1302/0301-620X.99B5.BJJ-2016-0562.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。